m8 Pharmaceuticals and Vectans Pharma signed an exclusive licensing agreement of Loramyc® (miconazole Lauriad®) for Mexico and Brazil.The indication for Loramyc® will be Oropharyngeal Candidiasis, for which Brazil is among the top 3 world markets.